APA (7th ed.) Citation

Baird, R. D., Kitzen, J., Clarke, P. A., Planting, A., Reade, S., Reid, A., . . . Verweij, J. (2009). Phase I safety, pharmacokinetic, and pharmacogenomic trial of ES-285, a novel marine cytotoxic agent, administered to adult patients with advanced solid tumors. Molecular cancer therapeutics, 8(6), 1430-1437. https://doi.org/10.1158/1535-7163.MCT-08-1167

Chicago Style (17th ed.) Citation

Baird, Richard D., et al. "Phase I Safety, Pharmacokinetic, and Pharmacogenomic Trial of ES-285, a Novel Marine Cytotoxic Agent, Administered to Adult Patients with Advanced Solid Tumors." Molecular Cancer Therapeutics 8, no. 6 (2009): 1430-1437. https://doi.org/10.1158/1535-7163.MCT-08-1167.

MLA (9th ed.) Citation

Baird, Richard D., et al. "Phase I Safety, Pharmacokinetic, and Pharmacogenomic Trial of ES-285, a Novel Marine Cytotoxic Agent, Administered to Adult Patients with Advanced Solid Tumors." Molecular Cancer Therapeutics, vol. 8, no. 6, 2009, pp. 1430-1437, https://doi.org/10.1158/1535-7163.MCT-08-1167.